Literature DB >> 25079809

The chemerin receptor CMKLR1 is a functional receptor for amyloid-β peptide.

Lei Peng1, Yang Yu1, Jin Liu1, Shuqin Li1, Huiqiong He1, Ni Cheng2, Richard D Ye3.   

Abstract

Amyloid-β peptides such as Aβ1-42 (Aβ42) play a pivotal role in the progression of Alzheimer's disease (AD). Aβ42 is neurotoxic and can activate microglial cells. These cells in turn migrate toward senile (neuritic) plaques and help to clear Aβ deposits through an endocytotic mechanism. It is of potential significance to characterize the Aβ42 receptors that mediate microglia chemotaxis and Aβ42 uptake. We found that the transcript of the chemerin receptor CMKLR1 was upregulated in the brain of AD patients and in mouse brain tissue following systemic LPS administration. CMKLR1 and Aβ42 colocalized in hippocampus and cortex of AβPP/PS1 transgenic mice. Moreover, Aβ42 bound specifically to CMKLR1 in stably transfected rat basophilic leukemia (RBL) cells (CMKLR1-RBL), suggesting that CMKLR1 is a receptor for Aβ42. Aβ42 induced migration of primary microglia, the mouse microglial cell line N9, and CMKLR1-RBL cells, but not untransfected RBL-2H3 cells. Mechanistic studies showed that Aβ42 induced CMKLR1-dependent cell migration through activation of the ERK1/2, PKA, and Akt pathways, but not Ca2+ mobilization. Aβ42 stimulation of CMKLR1-RBL cells and primary glial cells led to internalization of the Aβ42-CMKLR1 complex, suggesting a potential role for CMKLR1 in Aβ42 clearance. Taken together, these results indicate that Aβ42 activates CMKLR1, leading to glia cell migration and clearance of Aβ42. CMKLR1 is a new addition to the repertoire of cell surface molecules that are responsible for Aβ processing and clearance.

Entities:  

Keywords:  Alzheimer's disease; amyloid-β; chemerin receptor; chemotaxis; microglial cells

Mesh:

Substances:

Year:  2015        PMID: 25079809     DOI: 10.3233/JAD-141227

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  24 in total

Review 1.  Amyloid beta: structure, biology and structure-based therapeutic development.

Authors:  Guo-Fang Chen; Ting-Hai Xu; Yan Yan; Yu-Ren Zhou; Yi Jiang; Karsten Melcher; H Eric Xu
Journal:  Acta Pharmacol Sin       Date:  2017-07-17       Impact factor: 6.150

2.  A chimeric Cfh transgene leads to increased retinal oxidative stress, inflammation, and accumulation of activated subretinal microglia in mice.

Authors:  Bogale Aredo; Tao Li; Xiao Chen; Kaiyan Zhang; Cynthia Xin-Zhao Wang; Darlene Gou; Biren Zhao; Yuguang He; Rafael L Ufret-Vincenty
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

Review 3.  Gut Microbiota Disorder, Gut Epithelial and Blood-Brain Barrier Dysfunctions in Etiopathogenesis of Dementia: Molecular Mechanisms and Signaling Pathways.

Authors:  Menizibeya O Welcome
Journal:  Neuromolecular Med       Date:  2019-05-21       Impact factor: 3.843

Review 4.  Microglial Aβ receptors in Alzheimer's disease.

Authors:  Yang Yu; Richard D Ye
Journal:  Cell Mol Neurobiol       Date:  2014-08-23       Impact factor: 5.046

5.  The Chemokine-like Receptor 1 Deficiency Improves Cognitive Deficits of AD Mice and Attenuates Tau Hyperphosphorylation via Regulating Tau Seeding.

Authors:  Haibo Zhang; Aihua Lin; Ping Gong; Yanqing Chen; Richard D Ye; Feng Qian; Yan Zhang; Yang Yu
Journal:  J Neurosci       Date:  2020-08-12       Impact factor: 6.167

Review 6.  Targeting neuroinflammation in Alzheimer's disease.

Authors:  Maria Rosanna Bronzuoli; Aniello Iacomino; Luca Steardo; Caterina Scuderi
Journal:  J Inflamm Res       Date:  2016-11-03

7.  Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.

Authors:  Shu-Qin Li; Yang Yu; Jin-Zhao Han; Ding Wang; Jin Liu; Feng Qian; Guo-Huang Fan; Richard Bucala; Richard D Ye
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

8.  Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A.

Authors:  Jin Liu; Ding Wang; Shu-Qin Li; Yang Yu; Richard D Ye
Journal:  J Neuroinflammation       Date:  2016-02-02       Impact factor: 8.322

9.  The role of GPR1 signaling in mice corpus luteum.

Authors:  Ya-Li Yang; Li-Rong Ren; Li-Feng Sun; Chen Huang; Tian-Xia Xiao; Bao-Bei Wang; Jie Chen; Brian A Zabel; Peigen Ren; Jian V Zhang
Journal:  J Endocrinol       Date:  2016-05-05       Impact factor: 4.286

10.  Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.

Authors:  Zhengjun Zhang; Jijun Wang; Hongmei Wang
Journal:  Exp Ther Med       Date:  2018-01-16       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.